세계의 울혈성 심부전(CHF) 시장 보고서(2025년)

Congestive heart failure (CHF) is a chronic and progressive condition in which the heart's ability to effectively pump blood is compromised, leading to fluid buildup in the lungs, heart, liver, and other areas of the body. This results in symptoms such as shortness of breath, fatigue, swelling, and difficulty with daily activities, ultimately affecting overall quality of life and necessitating continuous medical management and treatment.

The main types of congestive heart failure (CHF) include systolic heart failure, diastolic heart failure, left-sided heart failure, and right-sided heart failure. Systolic heart failure occurs when the heart muscle is unable to pump blood efficiently, causing poor circulation. Treatment options include medications and surgery, with diagnostic methods such as electrocardiograms, echocardiograms, magnetic resonance imaging (MRI), stress tests, blood tests, and cardiac catheterization. These treatments and diagnostics are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. They are used by a wide range of end-users, such as hospitals, specialty clinics, ambulatory surgical centers, and homecare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The congestive heart failure (CHF) market research report is one of a series of new reports from The Business Research Company that provides Congestive Heart Failure (CHF) market statistics, including Congestive Heart Failure (CHF) industry global market size, regional shares, competitors with a Congestive Heart Failure (CHF) market share, detailed Congestive Heart Failure (CHF) market segments, market trends and opportunities, and any further data you may need to thrive in the Congestive Heart Failure (CHF) industry. This Congestive Heart Failure (CHF) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congestive heart failure (chf) market size has grown strongly in recent years. It will grow from $15.94 billion in 2024 to $16.94 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of aging population, increasing cardiovascular diseases, rise in awareness of heart health, increasing healthcare expenditure, growth demand for remote patient monitoring.

The congestive heart failure (chf) market size is expected to see strong growth in the next few years. It will grow to $21.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to rising adoption of digital health solutions, increasing prevalence of hypertension, rising obesity rates, improving patient outcomes, increased focus on personalized medicine. Major trends in the forecast period include advancements in diagnostic technologies, advancements in treatment options, technological advancements in imaging, innovations in therapeutic approaches, developments in wearable health devices.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cardiac care by increasing costs for ventricular assist devices and natriuretic peptide tests imported from Sweden and Italy, potentially worsening outcomes and raising heart failure clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in cardiovascular patients is expected to drive the growth of the congestive heart failure (CHF) market. Cardiovascular health pertains to the heart and blood vessels, and their role in circulating blood and maintaining the body's overall health. The increase in cardiovascular cases is attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and urbanization, all of which contribute to a higher demand for advanced healthcare and treatment options. CHF offers targeted solutions that enhance heart efficiency, alleviate symptoms, and prevent complications, improving patient care and overall health. For instance, in January 2023, the American College of Cardiology reported that cardiovascular disease cases reached 19.8 million in 2022. Additionally, Eastern Europe had the highest mortality rate, with 553 deaths per 100,000 people. As a result, the rise in cardiovascular cases is fueling growth in the CHF market.

Companies in the CHF market are prioritizing innovations, such as single intracoronary infusion therapies, to provide effective treatment options that enhance heart function and improve the quality of life for CHF patients. Single intracoronary infusion involves delivering medication directly into the coronary artery, targeting the heart for precise treatment of conditions such as CHF. For example, in January 2024, Bayer AG, a German pharmaceutical company, and Asklepios Biopharmaceutical, Inc., a U.S.-based biotechnology company, launched the GenePHIT Phase II trial for AB-1002, a gene therapy for CHF. This approach targets non-ischemic cardiomyopathy and represents a potential breakthrough in CHF treatment through genetic solutions. The trial, which is adaptive, double-blind, and placebo-controlled, will enroll between 90 and 150 participants who have been medically stable for at least four weeks and have a left ventricular ejection fraction between 15% and 35%.

In October 2024, Johnson & Johnson, a U.S.-based pharmaceutical company, acquired V-Wave Ltd., an Israel-based company focused on developing innovative treatments for congestive heart failure. This acquisition strengthens Johnson & Johnson's cardiovascular MedTech portfolio, particularly in heart failure care, with the Ventura Interatrial Shunt being one of the key solutions offered by V-Wave Ltd.

Major players in the congestive heart failure (chf) market are Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., LivaNova

North America was the largest region in the congestive heart failure (CHF) market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in congestive heart failure (CHF) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the congestive heart failure (CHF) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congestive heart failure (CHF) market consists of revenues earned by entities by providing cardiac treatment, hemodynamic monitoring, and therapeutic services. The market value includes the value of related goods such as diagnostic tools, monitoring devices, and support services. The congestive heart failure (CHF) market also includes sales of diagnostic tools, and testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congestive Heart Failure (CHF) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congestive heart failure (chf) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congestive heart failure (chf) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The congestive heart failure (chf) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Systolic Heart Failure; Diastolic Failure; Left-Sided Heart Failure; Right-Sided Heart Failure
• 2) By Treatment: Medication; Surgery
• 3) By Diagnosis: Electrocardiogram; Echocardiogram; Magnetic Resonance Imaging (MRI); Stress Test; Blood Tests; Cardiac Catheterization; Other Diagnosis
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Homecare Settings
• Subsegments:
• 1) By Systolic Heart Failure: Reduced Ejection Fraction (HFrEF); Mild-to-moderate Reduced Ejection Fraction
• 2) By Diastolic Heart Failure: Preserved Ejection Fraction (HFpEF); Borderline Ejection Fraction (HFpEF)
• 3) By Left-Sided Heart Failure: Acute Left-Sided Heart Failure; Chronic Left-Sided Heart Failure
• 4) By Right-Sided Heart Failure: Acute Right-Sided Heart Failure; Chronic Right-Sided Heart Failure
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Boehringer Ingelheim International GmbH; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG.; Medtronic Plc; Eli Lilly and Company; Canon Medical Systems Corporation; Novo Nordisk A/S; Jarvik Heart Inc.; Boston Scientific Corporation; Applied Molecular Genetics Inc.; Biotronik SE & Co. KG; Exelixis Pharmaceuticals Inc.; Otsuka Pharmaceutical Co. Ltd.; LivaNova
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Congestive Heart Failure (CHF) Market Characteristics

3. Congestive Heart Failure (CHF) Market Trends And Strategies

4. Congestive Heart Failure (CHF) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Congestive Heart Failure (CHF) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Congestive Heart Failure (CHF) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Congestive Heart Failure (CHF) Market Growth Rate Analysis
• 5.4. Global Congestive Heart Failure (CHF) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Congestive Heart Failure (CHF) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Congestive Heart Failure (CHF) Total Addressable Market (TAM)

6. Congestive Heart Failure (CHF) Market Segmentation

• 6.1. Global Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systolic Heart Failure
• Diastolic Failure
• Left-Sided Heart Failure
• Right-Sided Heart Failure
• 6.2. Global Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• 6.3. Global Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrocardiogram
• Echocardiogram
• Magnetic Resonance Imaging (MRI)
• Stress Test
• Blood Tests
• Cardiac Catheterization
• Other Diagnosis
• 6.4. Global Congestive Heart Failure (CHF) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Congestive Heart Failure (CHF) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• 6.6. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Systolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reduced Ejection Fraction (HFrEF)
• Mild-to-moderate Reduced Ejection Fraction
• 6.7. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Diastolic Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preserved Ejection Fraction (HFpEF)
• Borderline Ejection Fraction (HFpEF)
• 6.8. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Left-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Left-Sided Heart Failure
• Chronic Left-Sided Heart Failure
• 6.9. Global Congestive Heart Failure (CHF) Market, Sub-Segmentation Of Right-Sided Heart Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Right-Sided Heart Failure
• Chronic Right-Sided Heart Failure

7. Congestive Heart Failure (CHF) Market Regional And Country Analysis

• 7.1. Global Congestive Heart Failure (CHF) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Congestive Heart Failure (CHF) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Congestive Heart Failure (CHF) Market

• 8.1. Asia-Pacific Congestive Heart Failure (CHF) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Congestive Heart Failure (CHF) Market

• 9.1. China Congestive Heart Failure (CHF) Market Overview
• 9.2. China Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Congestive Heart Failure (CHF) Market

• 10.1. India Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Congestive Heart Failure (CHF) Market

• 11.1. Japan Congestive Heart Failure (CHF) Market Overview
• 11.2. Japan Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Congestive Heart Failure (CHF) Market

• 12.1. Australia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Congestive Heart Failure (CHF) Market

• 13.1. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Congestive Heart Failure (CHF) Market

• 14.1. South Korea Congestive Heart Failure (CHF) Market Overview
• 14.2. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Congestive Heart Failure (CHF) Market

• 15.1. Western Europe Congestive Heart Failure (CHF) Market Overview
• 15.2. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Congestive Heart Failure (CHF) Market

• 16.1. UK Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Congestive Heart Failure (CHF) Market

• 17.1. Germany Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Congestive Heart Failure (CHF) Market

• 18.1. France Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Congestive Heart Failure (CHF) Market

• 19.1. Italy Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Congestive Heart Failure (CHF) Market

• 20.1. Spain Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Congestive Heart Failure (CHF) Market

• 21.1. Eastern Europe Congestive Heart Failure (CHF) Market Overview
• 21.2. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Congestive Heart Failure (CHF) Market

• 22.1. Russia Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Congestive Heart Failure (CHF) Market

• 23.1. North America Congestive Heart Failure (CHF) Market Overview
• 23.2. North America Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Congestive Heart Failure (CHF) Market

• 24.1. USA Congestive Heart Failure (CHF) Market Overview
• 24.2. USA Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Congestive Heart Failure (CHF) Market

• 25.1. Canada Congestive Heart Failure (CHF) Market Overview
• 25.2. Canada Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Congestive Heart Failure (CHF) Market

• 26.1. South America Congestive Heart Failure (CHF) Market Overview
• 26.2. South America Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Congestive Heart Failure (CHF) Market

• 27.1. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Congestive Heart Failure (CHF) Market

• 28.1. Middle East Congestive Heart Failure (CHF) Market Overview
• 28.2. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Congestive Heart Failure (CHF) Market

• 29.1. Africa Congestive Heart Failure (CHF) Market Overview
• 29.2. Africa Congestive Heart Failure (CHF) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Congestive Heart Failure (CHF) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Congestive Heart Failure (CHF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Congestive Heart Failure (CHF) Market Competitive Landscape And Company Profiles

• 30.1. Congestive Heart Failure (CHF) Market Competitive Landscape
• 30.2. Congestive Heart Failure (CHF) Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Congestive Heart Failure (CHF) Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Abbott Laboratories
• 31.4. Novartis AG.
• 31.5. Medtronic Plc
• 31.6. Eli Lilly and Company
• 31.7. Canon Medical Systems Corporation
• 31.8. Novo Nordisk A/S
• 31.9. Jarvik Heart Inc.
• 31.10. Boston Scientific Corporation
• 31.11. Applied Molecular Genetics Inc.
• 31.12. Biotronik SE & Co. KG
• 31.13. Exelixis Pharmaceuticals Inc.
• 31.14. Otsuka Pharmaceutical Co. Ltd.
• 31.15. LivaNova

32. Global Congestive Heart Failure (CHF) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Congestive Heart Failure (CHF) Market

34. Recent Developments In The Congestive Heart Failure (CHF) Market

35. Congestive Heart Failure (CHF) Market High Potential Countries, Segments and Strategies

• 35.1 Congestive Heart Failure (CHF) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Congestive Heart Failure (CHF) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Congestive Heart Failure (CHF) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer